Brief: Genscript And Gladstone-Ucsf Institute Of Genomic Immunology Collaborate On Non-Viral Cell Therapy Study
Sept 22 (Reuters) - Genscript Biotech Corp 1548.HK :
* GENSCRIPT AND GLADSTONE-UCSF INSTITUTE OF GENOMIC
IMMUNOLOGY
COLLABORATE ON GROUNDBREAKING NON-VIRAL CELL THERAPY STUDY
* GENSCRIPT BIOTECH - STUDY DESCRIBES METHODS USING SSDNA
DONOR
TEMPLATES TO REDUCE CELLULAR TOXICITY AND ACHIEVE 40% KNOCK-IN
EDITING EFFICIENCY
Source text for Eikon: ID:nPn55PsZWa
Further company coverage: 1548.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale